XML 177 R6.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
¥ in Millions, $ in Millions
Total Alibaba Group Holding Limited shareholders' equity (deficits)
IPO
CNY (¥)
Total Alibaba Group Holding Limited shareholders' equity (deficits)
CNY (¥)
Ordinary Shares
Partner Capital Investment Plan
shares
Ordinary Shares
IPO
shares
Ordinary Shares
CNY (¥)
shares
Additional paid-in capital
IPO
CNY (¥)
Additional paid-in capital
CNY (¥)
Treasury shares
CNY (¥)
Restructuring reserve
CNY (¥)
Subscription receivables
CNY (¥)
Statutory reserves
CNY (¥)
Cumulative translation adjustments
CNY (¥)
Unrealized gain (loss) on available-for-sale securities, interest rate swaps and others
CNY (¥)
Retained earnings (Accumulated deficits)
CNY (¥)
Noncontrolling interest
Partner Capital Investment Plan
CNY (¥)
Noncontrolling interest
CNY (¥)
Partner Capital Investment Plan
CNY (¥)
IPO
CNY (¥)
USD ($)
shares
CNY (¥)
shares
Balance at Mar. 31, 2013   ¥ (24)     ¥ 1   ¥ 21,655 ¥ 0   ¥ (852) ¥ 1,337 ¥ (1,666) ¥ (8) ¥ (20,491)   ¥ 537       ¥ 513
Balance (in shares) at Mar. 31, 2013 | shares         2,175,220,739                              
Increase (Decrease) in Stockholders' Equity                                        
Foreign currency translation adjustment   552               16   536       2       554
Net change in unrealized gains on available-for-sale securities   293                     293             293
Change in fair value of interest rate swaps under hedge accounting   36                     36             36
Net income for the year   23,315                       23,315   88       23,403
Liquidation and deconsolidation of subsidiaries   (14)                   (14)               (14)
Acquisition of shares of a consolidated subsidiary   (7)         (7)                 (2)       (9)
Acquisition of subsidiaries   276         276                         276
Acquisition of subsidiaries (in shares) | shares         828,299                              
Issuance of ordinary shares                             ¥ 442   ¥ 442      
Issuance of ordinary shares (in shares) | shares     18,000,000                                  
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans   688         700     (12)                   688
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans (in shares) | shares         30,880,761                              
Repurchase and retirement of ordinary shares   (228)         (32)     308       (504)           (228)
Repurchase and retirement of ordinary shares (in shares) | shares         (3,943,139)                              
Amortization of compensation cost   2,784         2,784                 12       2,796
Equity-settled donation   1,269         1,269                         1,269
Issuance of ordinary shares in relation to investment in equity investees and others   637         637                         637
Issuance of ordinary shares in relation to investment in equity investees and others (in shares) | shares         5,824,000                              
Accretion to convertible preferred shareholders   (31)         (31)                         (31)
Dividend to convertible preferred shareholders   (208)         (208)                         (208)
Appropriation to statutory reserves                     1,137     (1,137)            
Balance at Mar. 31, 2014   29,338     ¥ 1   27,043 0   (540) 2,474 (1,144) 321 1,183   1,079       30,417
Balance (in shares) at Mar. 31, 2014 | shares         2,226,810,660                              
Increase (Decrease) in Stockholders' Equity                                        
Foreign currency translation adjustment   59                   49 10     (7)       52
Net change in unrealized gains on available-for-sale securities   3,102                     3,102             3,102
Change in fair value of interest rate swaps under hedge accounting   (36)                     (36)             (36)
Net income for the year   24,261                       24,261   63       24,324
Liquidation and deconsolidation of subsidiaries                     (26)     26   (378)       (378)
Acquisition of subsidiaries   3,782         3,782                 10,897       14,679
Acquisition of subsidiaries (in shares) | shares         8,876,755                              
Issuance of ordinary shares ¥ 61,536         ¥ 61,536                       ¥ 61,536    
Issuance of ordinary shares (in shares) | shares       149,220,834                                
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans   676         516     160                   676
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans (in shares) | shares         20,240,334                              
Repurchase and retirement of ordinary shares   (256)         (13)     6       (249)           (256)
Repurchase and retirement of ordinary shares (in shares) | shares         (892,859)                              
Deemed disposals of partial interest in subsidiaries arising from exercise or vesting of share-based awards   (7)         (7)                 17       10
Repurchase from, net of subscription, by noncontrolling interest for Partner Capital Investment Plan   (37)               (37)           (86)       (123)
Redemption of treasury shares granted for Senior Management Share Incentive Scheme   15         15                 (15)        
Capital injection from noncontrolling interests                               174       174
Amortization of compensation cost   12,659         12,659                 291       12,950
Excess value receivable arising from the restructuring of the commercial arrangements with Ant Financial Services and related amortization   166         1,318   ¥ (1,152)                     166
Conversion of convertible preferred shares   10,293         10,293                         10,293
Conversion of convertible preferred shares (In shares) | shares         91,243,312                              
Accretion to convertible preferred shareholders   (15)                       (15)           (15)
Dividend to convertible preferred shareholders   (97)                       (97)           (97)
Dividend declared by a consolidated subsidiary to noncontrolling interests                               (61)       (61)
Appropriation to statutory reserves                     267     (267)            
Balance at Mar. 31, 2015   145,439     ¥ 1   117,142 0 (1,152) (411) 2,715 (1,095) 3,397 24,842   11,974       ¥ 157,413
Balance (in shares) at Mar. 31, 2015 | shares         2,495,499,036                           2,495,499,036 2,495,499,036
Increase (Decrease) in Stockholders' Equity                                        
Foreign currency translation adjustment   240               (16)   24 232     56       ¥ 296
Net change in unrealized gains on available-for-sale securities   1,433                     1,433           $ 222 1,433
Change in fair value of forward exchange contracts under hedge accounting   (168)                     (168)           (26) (168)
Net income for the year   71,460                       71,460   (158)       71,302
Liquidation and deconsolidation of subsidiaries   21                   21       (10,849)       (10,828)
Acquisition of shares of a consolidated subsidiary   (30)         (30)                         (30)
Acquisition of subsidiaries                               31,409       31,409
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans   774         519     255                   774
Exercise of share options and vesting of early exercised options and RSUs, including repayment of related employee loans (in shares) | shares         25,016,386                              
Repurchase and retirement of ordinary shares   (19,795)         (2,774)             (17,021)           (19,795)
Repurchase and retirement of ordinary shares (in shares) | shares         (46,587,563)                              
Redemption of treasury shares granted for Senior Management Share Incentive Scheme   13         13                 (13)        
Capital injection from noncontrolling interests                               56       56
Amortization of compensation cost   16,434         16,434                 80       16,514
Tax benefits from share-based awards   725         725                         725
Amortization of excess value receivable arising from the restructuring of the commercial arrangements with Ant Financial Services and others   441         177   264                     441
Dividend declared by a consolidated subsidiary to noncontrolling interests                               (3)       (3)
Appropriation to statutory reserves                     529     (529)            
Balance at Mar. 31, 2016   ¥ 216,987     ¥ 1   ¥ 132,206 ¥ 0 ¥ (888) ¥ (172) ¥ 3,244 ¥ (1,050) ¥ 4,894 ¥ 78,752   ¥ 32,552     $ 38,700 ¥ 249,539
Balance (in shares) at Mar. 31, 2016 | shares         2,473,927,859                           2,473,927,859 2,473,927,859